Published in
Springer Nature [academic journals on nature.com], Blood Cancer Journal, 11(6), p. e496-e496, 2016
DOI: 10.1038/bcj.2016.106
Links
Tools
Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment
Journal article published in 2016 by
S. Betrian,
L. Ysebaert,
K. H. Heider,
J. P. Delord,
J. J. Fournié,
A. Quillet-Mary 
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 